Trademark Search in Canada

GLUCOSE SOS FOR PETS

View On IC.GC.CA

ABANDONED SECTION 36

on 18 Jul 2023

Last Applicant/ Owned by

SOS LIFE SCIENCES CORPORATION (DELAWARE CORPORATION)

706 North Lumina AvenueWrightsville Beach, NC 28480

Serial Number

1947854 filed on 22^nd Feb 2019

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

S4S7J7

GLUCOSE SOS FOR PETS

Trademark usage description

glucose dietary supplements; dietary supplements; dietary supplements for pets for the relief and treatment of anxiety, arthritis, depression, seizure Read More

Classification Information

Class [005]
Glucose dietary supplements; Dietary supplements; Dietary supplements for pets for the relief and treatment of anxiety, arthritis, depression, seizures, epilepsy, inflammation, joint and mobility issues, and glucose level control.

Classification kind code

Mark Details

Serial Number

1947854

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 6 on 18^th Jul 2023	Abandoned - Section 36
Submitted for opposition 14 on 25^th Apr 2023	Default Notice Sent
Submitted for opposition 22 on 6^th Oct 2022	Search Recorded
Submitted for opposition 20 on 6^th Oct 2022	Examiner's First Report
Submitted for opposition 287 on 11^th Apr 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 27^th Feb 2019	Formalized
Submitted for opposition 1 on 25^th Feb 2019	Created
Submitted for opposition 30 on 22^nd Feb 2019	Filed

GLUCOSE SOS FOR PETS

Classification Information

Class [005]Glucose dietary supplements; Dietary supplements; Dietary supplements for pets for the relief and treatment of anxiety, arthritis, depression, seizures, epilepsy, inflammation, joint and mobility issues, and glucose level control.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Glucose dietary supplements; Dietary supplements; Dietary supplements for pets for the relief and treatment of anxiety, arthritis, depression, seizures, epilepsy, inflammation, joint and mobility issues, and glucose level control.